MannKind (MNKD) moved up sharply today due to an exclusive agreement it signed with United Therapeutics. In the deal, MNKD allows United to be responsible for global development, regulatory and commercial activities for the development and commercialization of a product being developed by MNKD to treat pulmonary arterial hypertension. Here’s a recap of the trade signal this news triggered.
Read Similar Articles
We had a great example of a swing buy entry in NIO, Inc., the electric car company (Ticker: NIO). It’s based on a break out pattern on an hourly chart and confirmed with a daily chart. Click the video below to learn more details: Grab a free day pass to one of our live […]Read Article
The VIX and VXX are both very popular trading vehicles for trading volatility. But, unlike the perceptions of many traders, they are not exactly interchangeable. There are many similarities and more importantly, some very important differences. Click the video below to learn more details: Grab a free day pass to one of our live signal […]Read Article
We believe that some banks are in a position to make the next leg up? Why? You ask. Unlike your conventional banks, some banks like Goldman Sachs, JP Morgan, Citibank and, Morgan Stanley have resources that many conventional banks do not. They have MASSIVE trading entities. They are not simply a place to park […]Read Article